Wang H, et al. - During this study, researchers contemplated the risk of major congenital anomaly linked with first-trimester exposure to insulin analogues compared with human insulin in offspring of women with pregestational diabetes. No rise was noted in the risk of major congenital anomaly compared with exposure to human insulin. Data exhibited a possible lower risk of congenital heart defects among fetuses exposed to insulin analogues.